[Expert consensus on immunological prevention of human papillomavirus-related diseases]
- PMID: 31378039
- DOI: 10.3760/cma.j.issn.0253-9624.2019.08.001
[Expert consensus on immunological prevention of human papillomavirus-related diseases]
Abstract
Human papillomavirus (HPV)-related diseases such as cervical cancer have become a public health problem that seriously threatens human health. In response to the action plan for the elimination of cervical cancer, this consensus, on the basis of the World Health Organization position paper on HPV vaccine (2017) and the latest advances in research at home and abroad, provides an overview of HPV pathogens and the clinical, epidemiological and vaccine aspects of HPV related diseases. Through a comprehensive and systematic introduction of HPV disease-related knowledge, we aim to improve the level of prevention and control of HPV related diseases, especially to provide systematic and comprehensive evidence-based basis for professionals to use HPV vaccine scientificly.
子宫颈癌等人乳头瘤病毒相关疾病已成为严重威胁人类健康的公共卫生问题。为响应消除子宫颈癌行动计划，本共识在世界卫生组织关于人乳头瘤病毒疫苗立场文件（2017年）的基础上，结合国内外研究的最新进展，对HPV的病原学和所致相关疾病的临床学、流行病学、疫苗学等方面进行综述。通过HPV疾病相关知识的全面系统介绍，提高专业人员HPV相关疾病的防控水平；尤其在发挥HPV疫苗最佳预防作用及科学使用方面为专业人员提供系统、全面的循证依据。.
Keywords: Cervical Cancer; Human papillomavirus; Immunological prevention; Vaccination.
Similar articles
-
[Expert consensus on immunological prevention of human papillomavirus-related diseases (abridged)].Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Dec 10;40(12):1499-1516. doi: 10.3760/cma.j.issn.0254-6450.2019.12.002. Zhonghua Liu Xing Bing Xue Za Zhi. 2019. PMID: 32062907 Review. Chinese.
-
[Expert consensus on immunoprophylaxis of human papillomavirus-related diseases (abridged)].Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Dec 6;53(12):1218-1235. doi: 10.3760/cma.j.issn.0253-9624.2019.12.006. Zhonghua Yu Fang Yi Xue Za Zhi. 2019. PMID: 31795578 Review. Chinese.
-
[Expert consensus on immunoprophylaxis of cervical cancer and other human papillomavirus- related diseases (2025 edition)].Zhonghua Liu Xing Bing Xue Za Zhi. 2025 Jul 10;46(7):1107-1141. doi: 10.3760/cma.j.cn112338-20250530-00364. Zhonghua Liu Xing Bing Xue Za Zhi. 2025. PMID: 40619130 Chinese.
-
[Human papillomavirus infection and vaccination].Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Jan 6;52(1):106-112. doi: 10.3760/cma.j.issn.0253-9624.2018.01.021. Zhonghua Yu Fang Yi Xue Za Zhi. 2018. PMID: 29334719 Chinese.
-
Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.Future Oncol. 2017 Jun;13(13):1129-1132. doi: 10.2217/fon-2017-0147. Epub 2017 Jun 7. Future Oncol. 2017. PMID: 28589730
Cited by
-
Are HPV Vaccines Well Accepted among Parents of Adolescent Girls in China? Trends, Obstacles, and Practical Implications for Further Interventions: A Five-Year Follow-Up Study.Vaccines (Basel). 2024 Sep 19;12(9):1073. doi: 10.3390/vaccines12091073. Vaccines (Basel). 2024. PMID: 39340103 Free PMC article.
-
The correlation between multiple HPV infections and the occurrence, development, and prognosis of cervical cancer.Front Microbiol. 2023 Jul 28;14:1220522. doi: 10.3389/fmicb.2023.1220522. eCollection 2023. Front Microbiol. 2023. PMID: 37577444 Free PMC article.
-
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study.BMC Med. 2021 Mar 3;19(1):62. doi: 10.1186/s12916-021-01930-9. BMC Med. 2021. PMID: 33653331 Free PMC article.
-
Clinical significance of MATN1-AS1 as ceRNA of Mir-200b in tissues and serum of patients with cervical cancer.Sci Rep. 2023 Sep 15;13(1):15336. doi: 10.1038/s41598-023-42023-2. Sci Rep. 2023. PMID: 37714866 Free PMC article.
-
Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China.Indian J Gynecol Oncol. 2021;19(3):51. doi: 10.1007/s40944-021-00536-6. Epub 2021 Jun 27. Indian J Gynecol Oncol. 2021. PMID: 34222614 Free PMC article. Review.
